Edition:
United States

Intellipharmaceutics International Inc (IPCI.OQ)

IPCI.OQ on NASDAQ Stock Exchange Capital Market

1.84USD
4:00pm EDT
Change (% chg)

$0.12 (+6.98%)
Prev Close
$1.72
Open
$1.72
Day's High
$1.85
Day's Low
$1.70
Volume
36,470
Avg. Vol
19,240
52-wk High
$3.58
52-wk Low
$1.41

IPCI.OQ

Chart for IPCI.OQ

About

Intellipharmaceutics International Inc. is a pharmaceutical company specializing in the research, development and manufacture of controlled-release and targeted-release oral solid dosage drugs. The Company's Hypermatrix technology is a multidimensional controlled-release drug delivery platform that is applied to the development... (more)

Overall

Beta: 0.77
Market Cap(Mil.): $42.56
Shares Outstanding(Mil.): 25.06
Dividend: --
Yield (%): --

Financials

  IPCI.OQ Industry Sector
P/E (TTM): -- 39.19 39.69
EPS (TTM): -0.37 -- --
ROI: -1,577.25 15.23 14.44
ROE: -1,872.72 16.16 15.49

BRIEF-Intellipharmaceutics reports Q2 loss per share $0.08

* Q2 loss per share $0.08 Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

Jul 13 2016

BRIEF-Intellipharmaceutics announces pricing of $5.2 mln public offering

* Intellipharmaceutics announces pricing of $5.2 million public offering of common shares and warrants Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

May 27 2016

BRIEF-Intellipharmaceutics announces public offering of common shares and warrants

* Dawson James Securities, Inc. Is acting as sole bookrunner for offering

May 26 2016

BRIEF-Intellipharmaceutics reports Q1 loss per share $0.09

* Q1 earnings per share view $-0.10 -- Thomson Reuters I/B/E/S

Apr 15 2016

Competitors

  Price Chg
Merck & Co., Inc. (MRK.N) $58.66 +0.23
Novartis AG (NOVN.S) CHF80.30 0.00
Johnson & Johnson (JNJ.N) $125.23 +0.77
Pfizer Inc. (PFE.N) $36.89 +0.22

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : ValuEngine, Inc.
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Pechala's Reports
$25.00
Provider : Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.